Elephas

company

About

Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$41.50M
Industries
Artificial Intelligence,Biotechnology,Health Care,Health Diagnostics,Medical
Founded date
May 1, 2020
Number Of Employee
51 - 100
Operating Status
Active

Disruption in healthcare is accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision-making and accelerate drug development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$41.50M
Elephas has raised a total of $41.50M in funding over 2 rounds. Their latest funding was raised on Sep 6, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 6, 2022 Series B $41.50M 1 ARCH Venture Partners Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Elephas has made 2 investments. Their most recent investment was on Jan 1, 2019, when Blockchainova raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 1, 2019 Blockchainova
Seed Analytics
May 1, 2018 Athena Bitcoin
Seed Bitcoin

Investors

Number of Lead Investors
Number of Investors
1
1
Elephas is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Series B